abstract |
The present invention relates to a pharmaceutical composition for injection of a caspase inhibitor prodrug, and more particularly, to a caspase inhibitor prodrug as an active ingredient, or a pharmaceutically acceptable salt or isomer thereof, and It relates to an injectable pharmaceutical composition comprising a biocompatible polymer. |